Exosome-Based Liquid Biopsy for Real-Time Diagnosis and Assessment in Acute Stroke and Its Subtypes
Advances in Modern Biomedicine · 2025
DOI: 10.63623/y95rcx12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Modern Biomedicine, 2025. Verfasst von Gangadharan Thamizhoviya. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Acute stroke remained a leading cause of death and disability worldwide, emphasizing the need for rapid and accurate diagnostic tools to enable timely intervention. Conventional imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) provided structural insights but lacked real-time molecular-level information and were often time-consuming and resource-intensive. Despite advances in neuroimaging, rapid differentiation between the ischemic and hemorrhagic stroke in real time diagnosis remained a significant clinical challenge, mainly in resource-limited settings. Exosome-based liquid biopsy presented a minimally invasive alternative with the potential for rapid stroke subtype identification using molecular biomarkers. The present review explored the emerging role of exosome-based diagnostics in stroke differentiation, highlighting the modern technological advancements, clinical findings, key challenges, and future directions for integration into precision neurovascular care.
Zitieren
APA
Thamizhoviya, G. (2025). Exosome-Based Liquid Biopsy for Real-Time Diagnosis and Assessment in Acute Stroke and Its Subtypes. Advances in Modern Biomedicine. https://doi.org/10.63623/y95rcx12
Vancouver
Thamizhoviya G. Exosome-Based Liquid Biopsy for Real-Time Diagnosis and Assessment in Acute Stroke and Its Subtypes. Advances in Modern Biomedicine. 2025. doi:10.63623/y95rcx12
BibTeX
@article{Thamizhoviya2025,
author = {Thamizhoviya, Gangadharan},
title = {Exosome-Based Liquid Biopsy for Real-Time Diagnosis and Assessment in Acute Stroke and Its Subtypes},
journal = {Advances in Modern Biomedicine},
year = {2025},
doi = {10.63623/y95rcx12}
}
EUVIMED